MDxHealth Expands US Insurance Coverage for Prostate Cancer Test | GenomeWeb

NEW YORK (GenomeWeb News) – MDxHealth said today that it has signed up two additional US health insurance providers to cover its prostate cancer test.

Under the agreements, the company's ConfirmMDx for Prostate Cancer test will be covered by HealthSmart, a preferred provider organization network, and Fortified Provider Network.

The company said that with the new agreements more than 135 million people in the US can access the test through their insurance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.